Cargando…

Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA‐CKD

BACKGROUND: In participants with concomitant chronic coronary disease and advanced chronic kidney disease (CKD), the effect of treatment strategies on the timing of dialysis initiation is not well characterized. METHODS AND RESULTS: In ISCHEMIA‐CKD (International Study of Comparative Health Effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Briguori, Carlo, Mathew, Roy O., Huang, Zhen, Mavromatis, Kreton, Hickson, LaTonya J., Lau, Wei Ling, Mathew, Anoop, Mahajan, Sandeep, Wheeler, David C., Claes, Kathleen J., Chen, Gang, Nolasco, Fernando E. B., Stone, Gregg W., Fleg, Jerome L., Sidhu, Mandeep S., Rockhold, Frank W., Chertow, Glenn M., Hochman, Judith S., Maron, David J., Bangalore, Sripal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075321/ https://www.ncbi.nlm.nih.gov/pubmed/35261290 http://dx.doi.org/10.1161/JAHA.121.022003

Ejemplares similares

Frailty in CKD and Transplantation
por: Lorenz, Elizabeth C., et al.
Publicado: (2021)

Revascularization and survival in multivessel coronary artery disease in ischemia
por: Maron, David J., et al.
Publicado: (2022)

Clinical Implications of Coronary Microvascular Dysfunction in Patients with CKD
por: Elbaum, Lindsay, et al.
Publicado: (2022)

Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
por: Stenvinkel, Peter, et al.
Publicado: (2021)

Examining the safety and effectiveness of a 4-week supervised exercise intervention in the treatment of frailty in patients with chronic kidney disease
por: Lorenz, Elizabeth C, et al.
Publicado: (2023)

Severe Hyponatremia as the Initial Sign Preceding Guillain-Barré Syndrome, an Acute Inflammatory Demyelinating Polyneuropathy: A Case Report
por: Kloesel, Benjamin, et al.
Publicado: (2013)

What is the Real Message of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) Trial for Academic and Practising Cardiologists?
por: Mavromatis, Kreton, et al.
Publicado: (2020)

Complete Revascularization in Left Main Disease: Is it Important?
por: Mavromatis, Kreton, et al.
Publicado: (2023)

Screening for participants in the ISCHEMIA trial: Implications for clinical research
por: Rodriguez, Fatima, et al.
Publicado: (2022)

Acute renal allograft dysfunction due to cecal volvulus: a case report
por: Brown, Sherry-Ann N., et al.
Publicado: (2015)

Standardizing the Definition and Analysis Methodology for Complete Coronary Artery Revascularization
por: Ali, Ziad A., et al.
Publicado: (2021)

Procedural Volume and Outcomes After Primary Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction in Kerala, India: Report of the Cardiological Society of India–Kerala Primary Percutaneous Coronary Intervention Registry
por: Jabir, Abdullakutty, et al.
Publicado: (2020)

Invasive Management of Coronary Artery Disease in Advanced Renal Disease
por: Karimi Galougahi, Keyvan, et al.
Publicado: (2021)

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA‐CKD Trial
por: Chertow, Glenn M., et al.
Publicado: (2023)

Physician preferences for revascularization in patients with ischemic cardiomyopathy: Defining equipoise from web-based surveys
por: Mukhopadhyay, Amrita, et al.
Publicado: (2023)

Cellular senescence: the good, the bad and the unknown
por: Huang, Weijun, et al.
Publicado: (2022)

Effect of Erdosteine on Cyclosporine Induced Chronic Nephrotoxicity
por: Briguori, Carlo, et al.
Publicado: (2012)

Impaired Myocardial Oxygenation Response to Stress in Patients With Chronic Kidney Disease
por: Parnham, Susie, et al.
Publicado: (2015)

Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology
por: Venuthurupalli, Sree K., et al.
Publicado: (2018)

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives
por: Devabhaktuni, Madhuri, et al.
Publicado: (2009)

The State of Coronary Thrombus Aspiration
por: Pruthi, Sonal, et al.
Publicado: (2022)

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
por: Heerspink, Hiddo J L, et al.
Publicado: (2020)

CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia
por: Venuthurupalli, Sree K., et al.
Publicado: (2017)

Alport Syndrome Classification and Management
por: Warady, Bradley A., et al.
Publicado: (2020)

Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD
por: Norris, Keith C., et al.
Publicado: (2019)

Prevention of Chronic kidney disease (CKD) in children
por: Pecoraro, Carmine
Publicado: (2015)

Chronic kidney disease (CKD) in disadvantaged populations
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2015)

Cardiovascular Risk Factors: It's Time to Focus on Variability!
por: Barnett, Mallory P., et al.
Publicado: (2020)

A Case of Chronic Undiagnosed 2:1 Isolated Atrial Flutter in a Patient With an Autoimmune Disease
por: Clarke, Tegan, et al.
Publicado: (2023)

Emerging Role of Clinical Genetics in CKD
por: Devarajan, Prasad, et al.
Publicado: (2022)

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
por: Wheeler, David C, et al.
Publicado: (2020)

Vitamin D resistance in chronic kidney disease (CKD)
por: Parikh, Amay, et al.
Publicado: (2014)

Vitamin D and methylarginines in chronic kidney disease (CKD)
por: Torino, Claudia, et al.
Publicado: (2017)

The Role of Wnt Signalling in Chronic Kidney Disease (CKD)
por: Malik, Soniya A., et al.
Publicado: (2020)

Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective
por: Lohia, Sonnal, et al.
Publicado: (2022)

Atherosclerosis Specific Features in Chronic Kidney Disease (CKD)
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Proteomics of CKD progression in the chronic renal insufficiency cohort
por: Dubin, Ruth F., et al.
Publicado: (2023)

Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD
por: Park, Haesuk, et al.
Publicado: (2017)

Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Hamano, Takayuki, et al.
Publicado: (2022)

Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
por: Yamada, Shunsuke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_52l6kpbp0lks316vb3v1vk2fj3